Reported 11 months ago
Goldman Sachs anticipates difficulties in stock picking due to rising bond yields and high valuations impacting equity markets, with strategist Peter Oppenheimer suggesting diversification for investors in a flat market. Despite this, Goldman analysts recommend Jazz Pharmaceuticals (JAZZ) and Zeekr Intelligent Technology (ZK) as Strong Buy stocks with notable growth potential. JAZZ, a biotech firm with successful approved medications and a promising pipeline, is endorsed for its quality pipeline and trading at a discount, offering a 55% upside potential. On the other hand, ZK, a luxury EV brand partly owned by Geely, is praised for its asset-light manufacturing model and cost-efficient operations, leading to a 44% one-year upside potential. Both stocks have a Strong Buy consensus among the analysts surveyed.
Source: YAHOO